All questionsPharmacology: Xarelto (rivaroxaban), all indications5 questions · 1 sourceMechanismWhat type of drug is Xarelto?“XARELTO is a factor Xa inhibitor indicated:” (opens the source at this quote in a new tab)CopyFlag“Rivaroxaban, a factor Xa (FXa) inhibitor, is the active ingredient in XARELTO® Tablets and XARELTO® for oral suspension” (opens the source at this quote in a new tab)CopyFlagHow does Xarelto work (mechanism of action)?“XARELTO is a selective inhibitor of FXa. It does not require a cofactor (such as Anti-thrombin III) for activity. Rivaroxaban inhibits free FXa and prothrombinase activity. Rivaroxaban has no direct effect on platelet aggregation, but indirectly inhibits platelet aggregation induced by thrombin. By inhibiting FXa, rivaroxaban decreases thrombin generation.” (opens the source at this quote in a new tab)CopyFlagPharmacokineticsHow long does Xarelto stay in your system (half-life)?“Rivaroxaban is a low-clearance drug, with a systemic clearance of approximately 10 L/hr in healthy volunteers following intravenous administration. The terminal elimination half-life of rivaroxaban is 5 to 9 hours in healthy subjects aged 20 to 45 years.” (opens the source at this quote in a new tab)CopyFlag“The terminal elimination half-life is 11 to 13 hours in the elderly subjects aged 60 to 76 years” (opens the source at this quote in a new tab)CopyFlagNote: The label gives the half-life in healthy subjects aged 20 to 45 years and in elderly subjects aged 60 to 76 years.How is Xarelto metabolized and eliminated?“Approximately 51% of an orally administered [14C]-rivaroxaban dose was recovered as inactive metabolites in urine (30%) and feces (21%). Oxidative degradation catalyzed by CYP3A4/5 and CYP2J2 and hydrolysis are the major sites of biotransformation. Unchanged rivaroxaban was the predominant moiety in plasma with no major or active circulating metabolites.” (opens the source at this quote in a new tab)CopyFlag“In a Phase 1 study, following the administration of [14C]-rivaroxaban, approximately one- third (36%) was recovered as unchanged drug in the urine and 7% was recovered as unchanged drug in feces. Unchanged drug is excreted into urine, mainly via active” (opens the source at this quote in a new tab)CopyFlag“tubular secretion and to a lesser extent via glomerular filtration (approximate 5:1 ratio).” (opens the source at this quote in a new tab)CopyFlagNote: The second and third passages are one sentence that continues from page 12 to page 13 of the Prescribing Information.ComponentsWhat are the inactive ingredients in Xarelto tablets?“Each XARELTO tablet contains 2.5 mg, 10 mg, 15 mg, or 20 mg of rivaroxaban. The inactive ingredients of XARELTO are: croscarmellose sodium, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and sodium lauryl sulfate. Additionally, the proprietary film coating mixture used for XARELTO 2.5 mg is Opadry® Light Yellow, containing ferric oxide yellow, hypromellose, polyethylene glycol 3350, and titanium dioxide, and for XARELTO 10 mg tablets is Opadry® Pink and for XARELTO 15 mg tablets is Opadry® Red, both containing ferric oxide red, hypromellose, polyethylene glycol 3350, and titanium dioxide, and for XARELTO 20 mg tablets is Opadry® II Dark Red, containing ferric oxide red, polyethylene glycol 3350, polyvinyl alcohol (partially hydrolyzed), talc, and titanium dioxide.” (opens the source at this quote in a new tab)CopyFlag